NeuroX recently acquired the assets and operations of MindMaze, a world-renowned leader in evidence-based neurotherapeutic solutions for neurological diseases and brain disordersBusiness combination ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

Experts from the life sciences industry have shared key insights into how healthcare innovation is changing and the next wave of medicines.The ...

The UK’s new industrial strategy signals a decisive shift toward state-backed innovation, investment, and regulatory reform.

In this video interview, Michael Miller, chief operating officer at Quanterix, discusses how the use of biomarkers is ...

Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co.

On July 24, 2025, the Federal Trade Commission (“FTC”) and the U.S. Department of Justice (“DOJ”) convened the second of ...

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QUANTDx™, a ...

The medicinal cannabis industry could be facing further regulatory changes to ensure the safety of patients, amid record ...

Wall Street stocks had a mixed session overnight, with the Dow Jones dipping 0.1%, the S&P 500 just one point above flat and ...